Drug + Digital: Building a Unified Marketing Strategy
Drug + digital is no longer a future concept. Today, therapies often launch alongside companion apps, AI-driven algorithms, and remote monitoring platforms. Yet many...
Marketing After the Merger: Integrating Brands, Martech, and Teams in Pharma M&A
Pharma mergers often look powerful on paper. Revenue grows, pipelines expand, and market share increases overnight. However, successful marketing integration after a pharma acquisition...
Portfolio Over Brand: How Pharma Marketing Must Evolve Beyond Single-Product Thinking
What happens when a company launches three oncology brands in the same year, all targeting overlapping specialists? In many cases, internal competition rises, media...
The Data-Gradient Strategy: Why Global Pharma Campaigns Need Variable Personalization
Global pharma campaigns no longer operate on equal digital ground. Some markets lead with advanced AI, deep data integration, and predictive analytics. Others face...
Retail Health as a Marketing Channel: Designing Strategy for the Pharmacy-Clinic Hybrid
The role of retail health in pharmaceutical marketing is quickly evolving from a niche tactic into a core commercial growth strategy. As pharmacies expand...
From Campaigns to Capabilities: Rethinking Pharma Marketing Org Design for 2027
In today’s environment, the pharma marketing operating model has become the defining factor in digital success. While many teams still focus on launching better...
The Martech Reckoning: Evaluating AI Vendors in a Regulated Industry
Artificial intelligence is transforming healthcare marketing at record speed. However, with every new automation tool or predictive model comes a pressing question: is innovation...
Marketing in a Price-Control Era: How to Tell a Value Story Without Triggering Backlash
Drug pricing reform is no longer a distant threat. It is here, and it is reshaping how companies position value, defend margins, and communicate...
When Compliance Becomes Strategy: Turning MLR Into a Commercial Advantage
Medical, legal, and regulatory review is often treated as a necessary slowdown. Teams expect delays, revisions, and difficult conversations. Yet the way MLR is...
Competing in a GLP-1 Saturated Market: Differentiation Beyond Clinical Claims
The GLP-1 boom has reshaped obesity and diabetes care almost overnight. Yet as more brands enter the space, a hard truth is emerging: clinical...
